Latest / The OBservations Podcast
Groundbreaking Research that Shows Flawed REMS Around Mifepristone, Part 1
Over the years, the FDA has repeatedly removed safeguards around abortion drugs. Its most recent major change removed the requirement to dispense them in person. What evidence did it rely on to decide they were safe for women?
In part one of this two-part episode of OBservations, Dr. Christina Francis is joined by Dr. Ingrid Skop, a longtime friend of the podcast and the new Director of Research at AAPLOG. Her recent peer-reviewed paper critically analyzes the FDA's 2021 mifepristone REMS modification rationale.
In this episode, we explore:
Dr. Skop's background and her new role, her 25 years…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.